Published in Health Business Week, September 30th, 2005
For the fourth quarter ending August 31, 2005, net sales are expected to be $113 to $114 million compared to the prior estimate for the quarter of $116 to $119 million.
The company's revised estimate for full fiscal year 2005 net sales is $453 to $454 million as compared to the previous estimate of $456 to $459 million.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.